Episode 74 with Dr. Markus Reindl on anti-MOG antibodies & pediatric demyelinating diseases.
Recent research suggests new roles for an old biomarker, autoantibodies to myelin oligodendrocyte glycoprotein, or MOG, a protein component of myelin. Among the new findings, these anti-MOG antibodies are particularly important in pediatric demyelinating diseases.
Recent research suggests new roles for an old biomarker, autoantibodies to myelin oligodendrocyte glycoprotein, or MOG, a protein component of myelin. Among the new findings, these anti-MOG antibodies are particularly important in pediatric demyelinating diseases.
Clinical Research, Laboratory Research